Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial

被引：0
|
作者：
Goette, Andreas
de Groot, Joris R.
Le Heuzey, Jean-Yves
Banach, Maciej
Huber, Kurt
Jin, James
Melino, Michael
Winters, Shannon M.
Themistoclakis, Sakis
Lip, Gregory
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Anticoagulants; Atrial fibrillation; Aging; Gender differences;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18190
引用
收藏
页数：2
相关论文
共 50 条
  • [1] IMPACT OF BODY MASS INDEX AND OBESITY ON CLINICAL OUTCOMES IN THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) RANDOMIZED TRIAL
    Lip, Greg
    Merino, Jose L.
    Banach, Maciej
    de Groot, Joris
    Maier, Lars
    Themistoclakis, Sakis
    Jin, James
    Melino, Michael
    Winters, Shannon
    Goette, Andreas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 518 - 518
  • [2] Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) randomized trial
    Lip, Gregory Y. H.
    Merino, Jose L.
    Banach, Maciej
    Al-Saady, Naab
    Jin, James
    Melino, Michael
    Winters, Shannon M.
    Koziel, Monika
    Goette, Andreas
    JOURNAL OF ARRHYTHMIA, 2020, 36 (03) : 430 - 438
  • [3] Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial
    Goette, Andreas
    Merino, Jose L.
    De Caterina, Raffaele
    Huber, Kurt
    Heidbuchel, Hein
    Jin, James
    Lip, Gregory Y. H.
    CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (11) : 1374 - 1380
  • [4] Effect of concomitant antiplatelet agents on clinical outcomes in the Edoxaban versus Warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
    Goette, A.
    Merino, J.
    De Caterina, R.
    Huber, K.
    Heidbuchel, H.
    Jin, J.
    Melino, M.
    Winters, S. M.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 205 - 206
  • [5] Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial
    Andreas Goette
    Jose L. Merino
    Raffaele De Caterina
    Kurt Huber
    Hein Heidbuchel
    James Jin
    Gregory Y. H. Lip
    Clinical Research in Cardiology, 2020, 109 : 1374 - 1380
  • [6] A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study
    Lip, Gregory Y. H.
    Merino, Jose
    Ezekowitz, Michael
    Ellenbogen, Kenneth
    Zamoryakhin, Dmitry
    Lanz, Hans
    Jin, James
    Al-Saadi, Naab
    Mercuri, Michele
    Goette, Andreas
    AMERICAN HEART JOURNAL, 2015, 169 (05) : 597 - U28
  • [7] Edoxaban vs warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial
    Lip, G. Y. H.
    Al-Saady, N.
    Hjortshoj, S. P.
    Goudev, A.
    Huber, K.
    Cohen, A. -A.
    Jin, J.
    Merino, M.
    Winters, S. M.
    Goette, A.
    EUROPEAN HEART JOURNAL, 2018, 39 : 414 - 414
  • [8] Edoxaban versus warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
    Koziel, Monika
    Al-Saady, Naab
    Hjortshoj, Soren P.
    Goudev, Assen
    Huber, Kurt
    Cohen, Ariel
    Jin, James
    Melino, Michael
    Winters, Shannon M.
    Goette, Andreas
    Lip, Gregory Y. H.
    CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (08) : 1018 - 1024
  • [9] Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study)
    Lip, Gregory Y. H.
    Merino, Jose L.
    Dan, G. Andrei
    Themistoclakis, Sakis
    Ellenbogen, Kenneth A.
    De Caterina, Raffaele
    Goudev, Assen
    Jin, James
    Melino, Michael
    Winters, Shannon M.
    Goette, Andreas
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (02): : 193 - 198
  • [10] Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
    Monika Kozieł
    Naab Al-Saady
    Søren P. Hjortshøj
    Assen Goudev
    Kurt Huber
    Ariel Cohen
    James Jin
    Michael Melino
    Shannon M. Winters
    Andreas Goette
    Gregory Y. H. Lip
    Clinical Research in Cardiology, 2020, 109 : 1018 - 1024
12345